Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema

Authors

  • Emily Y. Kim Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA, USA
  • Katherine C. Awh Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA, USA
  • Cecilia A. Larocca Department of Dermatology, Brigham and Women’s Hospital, 41 Louis Pasteur Avenue, Boston MA 02115, USA

DOI:

https://doi.org/10.2340/actadv.v103.12197

Keywords:

systemic drug-related intertriginous and flexural exanthema, SDIRFE, baboon syndrome, everolimus, drug rash, mtor inhibitor, drug eruption, skin toxicity, oncodermatology

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Harbaoui S, Litaiem N. Symmetrical drug-related intertriginous and flexural exanthema. StatPearls Publishing; 2021 [cited 2022 Sep 9]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539750/

Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004; 51: 297-310.

https://doi.org/10.1111/j.0105-1873.2004.00445.x DOI: https://doi.org/10.1111/j.0105-1873.2004.00445.x

Hasskarl J. Everolimus. In: Martens UM, editor. Small Molecules in Oncology [Internet]. Cham: Springer International Publishing; 2018 [cited 2022 Sep 9]. p. 101-23. (Recent Results in Cancer Research). Available from: https://doi.org/10.1007/978-3-319-91442-8_8

https://doi.org/10.1007/978-3-319-91442-8_8 DOI: https://doi.org/10.1007/978-3-319-91442-8_8

Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact Dermatitis 1984; 10: 97-100.

https://doi.org/10.1111/j.1600-0536.1984.tb00343.x DOI: https://doi.org/10.1111/j.1600-0536.1984.tb00343.x

Schuler AM, Smith EH, Chaudet KM, Bresler SC, Gudjonsson JE, Kroshinsky D, et al. Symmetric drug-related intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature. J Cutan Pathol 2021; 48: 1471-1479.

https://doi.org/10.1111/cup.14090 DOI: https://doi.org/10.1111/cup.14090

Kurtzman DJB, Oulton J, Erickson C, Curiel-Lewandrowski C. Everolimus-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). Dermat Contact Atopic Occup Drug 2016; 27: 76-77.

https://doi.org/10.1097/DER.0000000000000164 DOI: https://doi.org/10.1097/DER.0000000000000164

Tan SC, Tan JWL. Symmetrical drug-related intertriginous and flexural exanthema. Curr Opin Allergy Clin Immunol 2011; 11: 313-318.

https://doi.org/10.1097/ACI.0b013e3283489d5f DOI: https://doi.org/10.1097/ACI.0b013e3283489d5f

Downloads

Published

2023-12-19

How to Cite

Kim, E. Y., Awh, K. C., & Larocca, C. A. (2023). Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema. Acta Dermato-Venereologica, 103, adv12197. https://doi.org/10.2340/actadv.v103.12197

Issue

Vol. 103 (2023)

Section

Short Communication

Categories

License

Copyright (c) 2023 Emily Y. Kim, Katherine C. Awh, Cecilia A. Larocca

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC